Floatz logo

Eicosapentanoic Acid

FAP

S.L.A. Pharma AGPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the FAP cohort.

Asset / SponsorPhaseRating
Tegsedi
Ionis Pharmaceuticals, Inc.
Phase 3B
Eloxatin
Parabilis Medicines, Inc.
Phase 1/2CCC
Irinotecan
Parabilis Medicines, Inc.
Phase 1/2CCC
FLUOROURACILUM
Parabilis Medicines, Inc.
Phase 1/2CCC
Nivolumab
Parabilis Medicines, Inc.
Phase 1/2CCC

View all 12 →

Same molecule, other indications

Eicosapentanoic Acid is also rated in:

major depressive disorderDormant
BB
Indicative ·
68 / 100
View asset →
drug-induced dyskinesiaDormant
BB
Indicative ·
68 / 100
View asset →
ProdromeDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →